GlassScriptPhysician profile
Lucas Seibolt
NPI 1588074140
$36,829.26
in general payments reported to CMS, 2019-2025
32 companies · $13K in 2025
The $13K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,627 · 2020: $12K · 2021: $636 · 2022: $1,685 · 2023: $2,527 · 2024: $5,324 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $8,802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,840.49 |
| Food and Beverage | $8,802.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15,561.05 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Medtronic Vascular, INC. | $8,097.04 | 2019-2020 | |
| Abbott Laboratories | $6,518.79 | 2019-2025 | Amplatzer Amulet, Navitor, Mitraclip |
| E.R. Squibb & Sons, L.L.C. | $707.62 | 2022-2025 | Camzyos, Eliquis |
| Abiomed | $678.51 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $628.36 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $627.23 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $535.43 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $472.62 | 2020-2025 | Farxiga, Andexxa |
| Merck Sharp & Dohme LLC | $412.14 | 2022-2025 | Verquvo |
| Shockwave Medical, INC | $347.22 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $303.34 | 2019-2024 | Lifevest |
| Medical Device Business Services, INC. | $279.99 | 2019 | |
| Pfizer INC. | $267.57 | 2021-2025 | |
| Boston Scientific Corporation | $245.62 | 2019-2025 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $166.45 | 2019 | |
| Amgen INC. | $165.70 | 2021-2025 | Repatha, Repatha |
| Alnylam Pharmaceuticals INC. | $153.49 | 2021-2025 | Amvuttra |
| Edwards Lifesciences Corporation | $125.36 | 2021-2024 | |
| Biosense Webster, INC. | $119.41 | 2019-2024 | Carto 3 |
| Daiichi Sankyo INC. | $91.03 | 2023-2024 | Injectafer |
| Bridgebio Pharma, INC. | $57.02 | 2025 | Attruby |
| Atricure, INC. | $54.85 | 2022-2023 | |
| Kestra Medical Technology Services, INC. | $52.53 | 2025 | Assure Wcd |
| Lantheus Medical Imaging, INC. | $41.58 | 2022-2023 | Definity |
| Esperion Therapeutics, INC. | $27.54 | 2021-2022 | |
| Inari Medical, INC. | $18.51 | 2022 | |
| Teleflex LLC | $15.81 | 2022 | |
| Chiesi USA, INC. | $15.23 | 2025 | Kengreal |
| Cleerly, INC. | $14.76 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Lilly USA, LLC | $13.81 | 2025 | Zepbound, Mounjaro |
| Asahi Intecc USA, INC. | $13.65 | 2024 | Peripheral Vascular |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucas Seibolt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.